Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2001

View Archived Issues

Mechanism of anticancer action of NB-1011 investigated

Xenerex and Eos enter antibody research alliance

Data presented for CX-659S this week at Japanese meeting support potential in dermatitis

Small molecule designed at Prescient NeuroPharma active in rat model of stroke

Structurally novel class of antiangiogenic agents discussed at Trends in Drug Research meeting

Binding, functional and immunological activity described for HS-378 in Noordwijkerhout

Taurolidine merits further investigation as a neuroprotectant according to recent findings

Atorvastatin reduces free radical production in VSMCs

LEP continues in active development for oncology indications

Phase I results for oral interferon tau support efficacy trials in MS patients

Elan to evaluate MyoBloc for additional indications

Raloxifene examined for long-term effects on cognitive function

Dimethaid Research seeks approval of Pennsaid via mutual recognition procedure

High-dose valaciclovir safe in MS patients treated for two years

Direct thrombin inhibitor LB-30057 compared with inogatran in rabbit thrombosis model

CPMP issues approvable letter for use of desloratadine in CIU

Polish scientists report on antiangiogenic effects of genistein in animal tumor models

UAB to evaluate Galenica's immunostimulator GPI-0100 for enhancing mucosal immunity

Idec prepares responses to FDA complete review letter for Zevalin

Genetronics collaborates with U.S. Navy on electroporation-mediated gene delivery

MTP inhibitors designed at Boehringer Ingelheim for use in lipid and related disorders

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

New antimitotic anticancer agents related to halichondrin synthesized and tested at Eisai

New agents from Takeda with the ability to enhance bone formation

Modulators of PGE receptors with improved toxicity discovered at Merck Frosst

Novel antibiotics produced by Nocardia useful for mycobacterial infections

Neurotrophic hydrazides emerge from R&D at Taisho

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...